Editorial: Key Players in Systemic Sclerosis: The Immune System and Beyond

Editorial: Key Players in Systemic Sclerosis: The Immune System and Beyond

Bibliographic Details
Main Authors:	Philippe Guilpain, Danièle Noël, Jérôme Avouac
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Immunology
Subjects:	systemic sclerosis pathophysiology co-stimulation abatacept innate immune system mesenchymal stromal cell
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.770419/full

Similar Items

Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
by: Pauline Rozier, et al.
Published: (2018-12-01)

Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells
by: Alexandre T. J. Maria, et al.
Published: (2018-11-01)

Targeting Costimulatory Pathways in Systemic Sclerosis
by: Gonçalo Boleto, et al.
Published: (2018-12-01)

iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic Sclerosis
by: Alexandre T. J. Maria, et al.
Published: (2018-12-01)

Lung Fibrosis Is Improved by Extracellular Vesicles from IFNγ-Primed Mesenchymal Stromal Cells in Murine Systemic Sclerosis
by: Pauline Rozier, et al.
Published: (2021-10-01)

Serum-Mediated Oxidative Stress from Systemic Sclerosis Patients Affects Mesenchymal Stem Cell Function
by: Guillaume Fonteneau, et al.
Published: (2017-09-01)

Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis
by: Pauline Rozier, et al.
Published: (2021-06-01)

Regulatory T Cells in Systemic Sclerosis
by: Camelia Frantz, et al.
Published: (2018-10-01)

T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosis
by: Gonçalo Boleto, et al.
Published: (2018-08-01)

Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors
by: Alexandre Thibault Jacques Maria, et al.
Published: (2019-01-01)

Impact of Innovative Treatment Using Biological Drugs for the Modulation of Diffuse Cutaneous Systemic Sclerosis: A Systematic Review
by: Diego Fernández-Lázaro, et al.
Published: (2023-01-01)

Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches
by: Devis Benfaremo, et al.
Published: (2022-01-01)

Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis
by: Anne Cauvet, et al.
Published: (2023-09-01)

Systemic sclerosis – review of current data and latest reports
by: Radosław Kasperski, et al.
Published: (2023-10-01)

Multiple Sclerosis as a Syndrome—Implications for Future Management
by: Christopher M. Dwyer, et al.
Published: (2020-08-01)

Oral Mesenchymal Stromal Cells in Systemic Sclerosis: Characterization and Response to a Hyaluronic-Acid-Based Biomaterial
by: Alina Stanomir, et al.
Published: (2021-08-01)

Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges
by: Juliette Peltzer, et al.
Published: (2018-09-01)

Enhanced Innate and Acquired Immune Responses in Systemic Sclerosis Primary Peripheral Blood Mononuclear Cells (PBMCs)
by: Iulia Szabo, et al.
Published: (2023-09-01)

Improvement in the clinical manifestations of interstitial lung disease following treatment with placental mesenchymal stromal cell extracellular vesicles in a patient with systemic sclerosis: A case report
by: Shirin Assar, et al.
Published: (2023-01-01)

CTLA-4 gene mutation and multiple sclerosis: A case report and literature review
by: Ting-Wei Lin, et al.
Published: (2022-06-01)

French recommendations for the management of systemic sclerosis
by: Eric Hachulla, et al.
Published: (2021-07-01)

Umbilical-Cord-Derived Mesenchymal Stromal Cells Modulate 26 Out of 41 T Cell Subsets from Systemic Sclerosis Patients
by: Paula Laranjeira, et al.
Published: (2023-04-01)

Hospitalization Risks for Neurological Disorders in Primary Sjögren’s Syndrome Patients
by: Radjiv Goulabchand, et al.
Published: (2022-04-01)

Essential immune functions of fibroblasts in innate host defense
by: Kellen J. Cavagnero, et al.
Published: (2022-12-01)

Calcinosis in systemic sclerosis: prevalence, clinical picture, management, complications
by: Ye.D. Yehudina, et al.
Published: (2019-04-01)

Clinical Efficacy and Safety of Injection of Stromal Vascular Fraction Derived from Autologous Adipose Tissues in Systemic Sclerosis Patients with Hand Disability: A Proof-Of-Concept Trial
by: Youngjae Park, et al.
Published: (2020-09-01)

Innate lymphoid cells: a new key player in atopic dermatitis
by: Haiping Jia, et al.
Published: (2023-10-01)

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis
by: Antonio Uccelli, et al.
Published: (2019-05-01)

Mesenchymal stem cells in systemic sclerosis therapy
by: Daniel Witold Dudek, et al.
Published: (2020-10-01)

Pathogenesis of systemic sclerosis
by: Debendra ePattanaik, et al.
Published: (2015-06-01)

Editorial: Measuring progression in Multiple Sclerosis: Progressing beyond the ordinary
by: Carynn Koch, et al.
Published: (2022-11-01)

Optimization of Optical Image Geometric Modeling, Application to Topography Extraction and Topographic Change Measurements Using PlanetScope and SkySat Imagery
by: Saif Aati, et al.
Published: (2020-10-01)

Complex deformation of cartilage micropellets following mechanical stimulation promotes chondrocyte gene expression
by: Noémie Petitjean, et al.
Published: (2023-08-01)

Mastitis in Autoimmune Diseases: Review of the Literature, Diagnostic Pathway, and Pathophysiological Key Players
by: Radjiv Goulabchand, et al.
Published: (2020-03-01)

Mesenchymal Stem/Stromal Cell-Based Therapies in Systemic Rheumatic Disease: From Challenges to New Approaches for Overcoming Restrictions
by: Bong-Woo Lee, et al.
Published: (2023-06-01)

CTLA-4Ig Improves Hyperalgesia in a Mouse Model of Osteoporosis
by: Nobuto Nagao, et al.
Published: (2020-12-01)

Desarrollo de psoriasis durante el tratamiento con Abatacept en artritis reumatoidea
by: J.A. Riera, et al.
Published: (2019-06-01)

Pre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis
by: C. Derambure, et al.
Published: (2017-05-01)

Innate Immunity in Systemic Sclerosis – Role of Toll-Like Receptors, Interferon, and the Potential Impact of Vitamin D
by: Ruxandra Ionescu, et al.
Published: (2014-07-01)

The Efficacy and Safety of Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis: A Pilot Study
by: Gholamreza Shamsaei, et al.
Published: (2023-03-01)